Engineered HSV for the Treatment of Malignant Glioma - Project 3 - Preclinical Evaluation of Oncolytic HSV for Anaplastic Glioma Therapy

Grant

Awarded By

Total Award Amount

  • 966703.00

    • Direct Costs

  • 659989.00

    • Sponsor Award Id

  • 5P01CA071933

    • Contributor

  • George Gillespie   Investigator  
  • James Markert M.D., M.P.H.   Investigator  
  • Richard Whitley M.D.   Principal Investigator